Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia-Reference-Cited by-同舟云学术

Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia

Published:2022-08-01 Issue:9 Volume:38 Page:1621-1630
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Tidmore Laura M.¹^ORCID,Keast Shellie L.²,Waters Heidi C.³,Pareja Kristin L.³,Cothran Terry⁴,Skrepnek Grant H.¹^ORCID

Affiliation:

1. Department of Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA

2. Government Human Services Consulting, Mercer LLC, Phoenix, AZ, USA

3. Health Outcomes, Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ, USA

4. Department of Pharmacy, Oklahoma Health Care Authority, Oklahoma City, OK, USA

Funder

University of Oklahoma Health Sciences Center by Otsuka Pharmaceutical Development and Commercialization, Inc.

Otsuka Pharmaceutical Development and Commercialization, Inc.

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2101819

Reference42 articles.

1. The cost of relapse and the predictors of relapse in the treatment of schizophrenia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations;Journal of Clinical Psychopharmacology;2024-01-16

2. Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation;Advances in Therapy;2022-11-08